शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans

This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →

APOLLOHOSPNSEAPOLLO HOSPITALS ENTER. L· Healthcare ServicesHighNeutral
Announced Wed, 4 Nov, 2026 · 18:16 IST

Consolidated Sep quarter versus year ago: revenue up 23%, profit after tax up over 30%

Revenue growth above 20%Results restatedProfit growth above 25%Results View source PDFExplain this filing

APOLLOHOSP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-2.3%Reaction day
₹8562.50
prior close
₹8645.00
announcement price
After-mkt
timing
Nifty 100marketpendingvs market: pending
Hospital peers, median of 27sector+0.4%-2.6% vs sector

On the reaction day the stock moved 2.6 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-3.0
10m
-3.1
15m
-3.4
30m
-3.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-2.3pendingpending+0.4-2.6
Next day
-1.4pendingpending-0.5-0.8
2d
—————
3d
—————
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty 100Sector · Hospital peers, median of 27Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Consolidated quarter ended 30 September 2026 versus year ago: operating revenue rose 23% to Rs 76,149 million from Rs 61,888 million; profit after tax rose over 30% to above Rs 6 billion from under Rs 5 billion. Earlier figures were reclassified for discontinued operations. Apollo sold two subsidiaries to Kids Clinic India for Rs 7,650 million cash plus a 9.9% stake worth Rs 2,850 million. Digital health split awaits court approval.

Likely market impact

Revenue and profit growth are positive, and the sale may release cash, but the planned separation and leadership transition create execution risk.

By the numbersConsolidated · Q2 FY27 vs Q2 FY26
Q2 FY27Q2 FY26Change
Revenue₹7,615 Cr₹6,304 Cr+20.8%
Operating profit₹846.6 Cr₹613.7 Cr+38.0%
Profit after tax₹659.5 Cr₹494.0 Cr+33.5%
EBITDA margin15.6%14.9%+0.7 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.